| |
| | F.D.A. Puts Restrictions on Guidant - New York Times (Site not responding. Last check: ) |
 | | In the letter, sent a week ago, the agency said Guidant, the heart device maker, had not fully responded to its concerns about manufacturing procedures at the company's biggest plant. |
 | | The latest warning letter, which was dated Dec. 22, raised eight specific deficiencies and threatened more severe penalties, like seizures, injunctions and fines, if the company did not promptly fix the problems. |
 | | Cordis, a Johnson & Johnson subsidiary, received an F.D.A. warning letter in April 2004, concerning its record-keeping, processing of complaints and production of its Cypher stents, which are drug-coated metal sleeves that prop open coronary arteries after blockages have been cleared. |
| www.nytimes.com /2005/12/28/business/28guidant.html?ex=1293426000&en=051204068909c621&ei=5088&partner=rssnyt&emc=rss (758 words) |
|